NANOREMEDI Functional Nano-Scaffolds for Regenerative Medicine
- Coordinator
- Universita Degli Studi Di Milano, Italy
- Runs
- 1 September 2022 to 30 November 2026
- Status
- Running
- EU funding
- €3.4m
- Total cost
- —
- Partners
- 19 organisations in 5 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101072645
What the project is doing
In the project's own words, from its summary on CORDIS.
Repair or replacement of tissue and organ functions lost due to age, disease or damage represents one of the most urgent medical needs of our aging society. The NanoReMedi Consortium will contribute to addressing this fundamentally important issue by using a new and efficient scientific approach relying on the design, preparation, characterization and validation of conceptually innovative peptide-based functional nanomaterials for regenerative medicine applications.
Specifically, NanoReMedi will tackle three highly relevant case studies: “Tissue engineered vascular grafts to replace damaged peripheral arteries”, “Stem-cell based regenerative medicine for bone and cartilage repair” and “Facing with implantation failure” this last addressed to overcome bacterial severe infections. As an equally important goal, the NanoReMedi Consortium aims to build a world-class doctoral educational model in the field of nanomaterials applied to regenerative nanomedicine, through a strategically designed Academia-Industry interplay.
To this end, 6 Beneficiaries, one Associated Partner linked to a beneficiary and 12 non-academic associated partners will join their forces to: i)create a highly innovative research network for training a new generation of 13 Doctoral Candidates (DCs) with strong employment potential, aimed at studying and developing “Functional Nano-Scaffolds for Regenerative Medicine”; ii)establish a robust structure for long-term research cooperation between a pool of leading Universities and Enterprises, for broadening and strengthening the knowledge and skills of DCs accessing the nanoscience-area from adjacent disciplines (such as chemistry, material sciences and bioinformatics); iii)building a solid foundation for long-term European excellence in medical nanotechnology via dissemination of research/training outcomes - through cross-network secondments, Summer Schools workshops and transferable skills modules, and of the best practice generated by NanoReMedi.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universita Degli Studi Di Milano | Milano | Italy | Coordinator |
| Edelweiss Connect GmbH | Basel | Switzerland | Associatedpartner |
| Asociacion Centro De Investigacion Cooperativa En Nanociencias Cic Nanogune | San Sebastian | Spain | Participant |
| Ponti & Partners, SLP | Barcelona | Spain | Associatedpartner |
| Simune Atomistics SL | Donostia San Sebastian | Spain | Associatedpartner |
| Universidad Del Pais Vasco/ Euskal Herriko Unibertsitatea | Leioa | Spain | Associatedpartner |
| Universitat Politecnica De Catalunya | Barcelona | Spain | Participant |
| Genepep SA | Saint Jean De Vedas | France | Associatedpartner |
| Lynxter | Bayonne | France | Associatedpartner |
| Universite De Montpellier | Montpellier | France | Participant |
| The Hebrew University of Jerusalem | Jerusalem | Israel | Participant |
| AB Medica SpA | Milano | Italy | Associatedpartner |
| Bayer HealthCare Manufacturing S.r.l. | Milano | Italy | Associatedpartner |
| Bio Basic Europe S.r.l. | Milano | Italy | Associatedpartner |
| De Lama spa | San Martino Siccomario | Italy | Associatedpartner |
| Italfarmaco S.p.a. | Milano | Italy | Associatedpartner |
| Jacobacci & Partners S.p.A. | Torino | Italy | Associatedpartner |
| Officine Innovazione SRL Societa' Benefit | Milano | Italy | Associatedpartner |
| Universita Degli Studi Di Pavia | Pavia | Italy | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI